U068 Staging, Work-up and Management of High Risk Cutaneous Squamous Cell Carcinoma
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
You will learn how to accurately stage patients with high risk cutaneous squamous cell carcinoma (SCC) and determine other factors beyond staging that can be important for prognosis, including genomic considerations. We will review appropriate pre/peri-operative imaging modalities. Lastly, we will discuss surgical approaches and multi-disciplinary management, including the latest updates on sentinel lymph node biopsy, radiation and systemic therapies, and offer case-based examples.
LEARNING OBJECTIVES
Accurately stage high risk cutaneous squamous cell carcinoma and consider additional prognostic factors.
Determine Pre/peri-operative imaging indications and modalities.
Assess the various surgical considerations and multidisciplinary approaches.
SCHEDULE
11:30 PM
Staging and other prognostic factors of high risk SCC
Kathleen Cook Suozzi, MD, FAAD
11:48 PM
Pre-/Post-operative work-up for patients with high risk SCC
Ashley Wysong, MD, MS, FAAD
12:05 AM
Treatment and Multidisciplinary Management
Mariam Totonchy, MD, FAAD
12:20 AM
Session Q&A
SPEAKERS
Kathleen Cook Suozzi, MD, FAAD
Mariam Totonchy, MD, FAAD
Ashley Wysong, MD, MS, FAAD
SPEAKER DISCLOSURES
Kathleen Cook Suozzi, MD, FAAD
No financial relationships exist with ineligible companies.
Mariam Totonchy, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria), Other(Honoraria); Sanofi/Regeneron – Speaker(Honoraria);
Ashley Wysong, MD, MS, FAAD
American College of Mohs Surgery – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding);